Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
about
Matrin 3 is a co-factor for HIV-1 Rev in regulating post-transcriptional viral gene expressionConstruction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virusIncreased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usageSam68 enhances the cytoplasmic utilization of intron-containing RNA and is functionally regulated by the nuclear kinase Sik/BRK.NXT1 (p15) is a crucial cellular cofactor in TAP-dependent export of intron-containing RNA in mammalian cells.Human immunodeficiency virus type 1 Rev is required in vivo for binding of poly(A)-binding protein to Rev-dependent RNAsEukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activationHIV-1 Rev oligomerization is not obligatory in the presence of an extra basic domainRTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAsHIV-1 and M-PMV RNA Nuclear Export Elements Program Viral Genomes for Distinct Cytoplasmic Trafficking Behaviors.Circularization of the HIV-1 RNA genomeInteractions between the HIV-1 Unspliced mRNA and Host mRNA Decay MachineriesFates of retroviral core components during unrestricted and TRIM5-restricted infectionEvidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNASafety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adultsMultiparameter RNA and codon optimization: a standardized tool to assess and enhance autologous mammalian gene expressionRNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments.Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intronAvian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasmNuclear interactions are necessary for translational enhancement by spleen necrosis virus RU5.The 5' RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production.A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques.Rev proteins of human and simian immunodeficiency virus enhance RNA encapsidation.Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefitRefined methods for propagating vesicular stomatitis virus vectors that are defective for G protein expression.Prostaglandin pathway gene therapy for sustained reduction of intraocular pressureProduction of avian leukosis virus particles in mammalian cells can be mediated by the interaction of the human immunodeficiency virus protein Rev and the Rev-responsive element.Control of human immunodeficiency virus type 1 RNA metabolism: role of splice sites and intron sequences in unspliced viral RNA subcellular distribution.Herpes simplex virus ICP27 induces cytoplasmic accumulation of unspliced polyadenylated alpha-globin pre-mRNA in infected HeLa cells.A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene.Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.The 5' RNA terminus of spleen necrosis virus stimulates translation of nonviral mRNAContributions of viral splice sites and cis-regulatory elements to lentivirus vector function.DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge.Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expressionIntronless mRNA transport elements may affect multiple steps of pre-mRNA processing.Nuclear RNA export and packaging functions of HIV-1 Rev revisitedGene therapy for infectious diseases
P2860
Q24315683-0F4A5F13-ECFF-4A57-AF27-B6091DF863FAQ24529091-5DAB330C-D2FE-43B7-BBDD-EDAC64F83F1BQ24531468-FE489A13-096D-41C8-889D-6DE8B559E991Q24540541-21E411A3-4801-4D5C-9485-4388B5F6FC18Q24550980-7A878AB0-C920-4E10-8BF9-5E38FF8EE0A8Q24645943-C34EA3B6-08FC-4D97-A5D7-232F1B1142B6Q24657633-2CA4BA95-FAE3-4DD1-98CA-945C295BF7B5Q24814560-A0A6B5E6-2AE6-452A-8AB2-C3B8ADDFEE07Q25256626-F870D7B2-39A1-4047-B933-6CE35C190F8CQ27314862-DEDA2F85-50C7-46BA-B3A8-35742EBABB93Q27481058-4D0573C0-8D6C-4ECC-8A60-B99FD87E096AQ28078564-302E6B0F-2C0F-48C1-9E47-F48CA2584C08Q28487732-295CA801-06A4-43BA-AC88-7CBCEDF3A080Q28646843-0FD1E9C2-CFC1-48A4-8857-0C61ACA0B952Q28740321-95A58316-0221-4951-9071-4E11B36B7CF8Q28742249-9D758C6E-02A6-446A-98CC-CB7B580CE084Q30252424-2CCD8966-6CAF-47E5-A962-71F72FE9B34FQ30450201-C4D99991-520C-4AF6-8865-359B04D306E7Q30450216-E93DD565-F867-48BF-9AE3-8A8B83894E3AQ30452134-1C5826D8-AFC2-41B3-9606-5548F7695CE0Q30452592-5F3F923E-22E7-4557-A135-2904EE5E435BQ30453281-342C8BDE-833E-4E1B-A54B-A1DE1FE7119AQ30453503-98C7548A-B3C1-4FAA-B682-E8A0269667B4Q30934059-740D5458-9E1E-4D79-9530-7A02136D16ECQ33282047-978EADAA-6C4C-4B09-B683-097AEB42D7B0Q33698152-37D737F1-83AE-4598-91FE-9D7BA4F95EF0Q33721746-BC2FD106-81AA-4D0D-A64D-5F03B12852A8Q33731140-636F0792-8770-482E-A335-C24D176996C7Q33735159-80A04E6F-1741-4D9E-8A50-DEB551C43AC8Q33785931-E63A8833-080A-4018-A297-CCE527DDD80CQ33800574-5A8EAC00-A04C-4F43-8474-8A44FA43034DQ33804963-EB478557-D156-430E-AF65-8C1BC07078B6Q33806715-92FA48A5-4261-4387-B645-198E1C26AC12Q33810910-08F9E9DB-C1B8-499F-BCE0-0AE130BA381DQ33816167-650CC89A-263E-44A9-AA3C-DA709126D52EQ33843297-D97AF85A-D996-46E6-8959-7A0299F45839Q33851952-7B8060D1-B301-4F65-917E-43B9FA0E5E61Q33890618-F7111C31-7E11-4FE0-A7DA-EF15F4B672ABQ33990559-F16D35A7-EDE5-4833-B4E5-7EC5D1847F1AQ33992464-0A6E1834-386E-4304-85E0-3A8B030DF0E8
P2860
Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Distinct RNA sequences in the ...... in the absence of Rev protein.
@ast
Distinct RNA sequences in the ...... in the absence of Rev protein.
@en
type
label
Distinct RNA sequences in the ...... in the absence of Rev protein.
@ast
Distinct RNA sequences in the ...... in the absence of Rev protein.
@en
prefLabel
Distinct RNA sequences in the ...... in the absence of Rev protein.
@ast
Distinct RNA sequences in the ...... in the absence of Rev protein.
@en
P2093
P2860
P1433
P1476
Distinct RNA sequences in the ...... in the absence of Rev protein.
@en
P2093
B K Felber
G N Pavlakis
S Schwartz
P2860
P304
P407
P577
1992-01-01T00:00:00Z